IP Library Granted Patent US 11,150,255
Granted Patent B2
US 11,150,255 · App. 15/648,182 · Granted Oct 19, 2021

Additive channels

Inventors: Daniel Levner (Brookline, MA); Christopher David Hinojosa (Cambridge, MA); Norman Wen (West Roxbury, MA); Jacob Fraser (Somerville, MA); Justin Nguyen (Medford, MA); Riccardo Barrile (Boston, MA); Geraldine Hamilton (Boston, MA); Catherine Karalis (Brookline, MA); Hyoungshin Park (Newton, MA); Antonio Varone (West Roxbury, MA); Andries Van der Meer (Enchede, NL); Monicah Otieno (Robbinville, NJ); David Conegliano (Boston, MA)
Assignee: EMULATE, Inc.
G01N33/86B01L3/5023B01L3/502707B01L3/502715B01L3/502746B01L3/502761C12M23/16C12M29/00C12M29/04C12M29/10C12M35/08C12M41/46G01N33/54366G01N33/80B01L2200/02B01L2200/027B01L2200/0605B01L2200/0647B01L2200/16B01L2300/0809B01L2300/0816B01L2300/0867B01L2300/0883B01L2300/0887B01L2300/14B01L2300/16G01N2500/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,150,255
App. No.
15/648,182
Granted
Oct 19, 2021
Kind
B2
Abstract

Compositions, devices and methods are described for preventing, reducing, controlling or delaying adhesion, adsorption, surface-mediated clot formation, or coagulation in a microfluidic device or chip. In one embodiment, blood (or other fluid with blood components) that contains anticoagulant is introduced into a microfluidic device comprising one or more additive channels containing one or more reagents that will re-activate the native coagulation cascade in the blood that makes contact with it “on-chip” before moving into the experimental region of the chip.

Claims (44)

1. A system comprising:

a) a microfluidic device comprising:

an input channel;

an output channel;

a test channel disposed in a solid substrate, wherein said test channel comprises an input portion in fluidic communication with said input channel and an output portion in fluidic communication with said output channel;

endothelial cells disposed within at least one portion of said test channel; and

an output additive channel, wherein said output additive channel is in fluidic communication with said output portion of said test channel;

b) an input channel reservoir in fluidic communication with said input channel;

c) an output additive channel reservoir in fluidic communication with said output additive channel, said output additive channel reservoir comprising one or more reagents that inactivate a native coagulation cascade of blood; and

d) a pressure source adapted to apply pressure to both said input channel reservoir and said output additive channel reservoir.

2. The system of claim 1 , wherein said output additive channel is configured to provide a fluidic resistance that is proportional to the fluidic resistance of said input channel.

3. The system of claim 1 , wherein said output additive channel comprises a first fluidic resistor, and input channel comprises a second fluidic resistor.

4. The system of claim 1 , wherein said endothelial cells are living cells.

5. The system of claim 4 , wherein said living cells form a lumen.

6. A system comprising:

a) a microfluidic device comprising:

an input channel;

an output channel;

a test channel, wherein said test channel comprises an input portion in fluidic communication with said input channel and an output portion in fluidic communication with said output channel;

endothelial cells disposed within at least one portion of said test channel; and

an output additive channel, wherein said output additive channel is in fluidic communication with said output portion of said test channel;

b) an input channel reservoir in fluidic communication with said input channel;

c) an output additive channel reservoir in fluidic communication with said output additive channel, said output additive channel reservoir and comprising one or more reagents that inactivate a native coagulation cascade of blood and is integrated on the microfluidic device; and

d) a pressure source adapted to apply pressure to both said input channel reservoir and said output additive channel reservoir.

7. The system of claim 6 , wherein said output additive channel is configured to provide a fluidic resistance that is proportional to the fluidic resistance of said input channel.

8. The system of claim 6 , wherein said output additive channel comprises a first fluidic resistor, and input channel comprises a second fluidic resistor.

9. The system of claim 6 , wherein said endothelial cells are living cells and said living endothelial cells form a lumen.

10. A system comprising:

a) a microfluidic device comprising:

an input channel;

an output channel;

a test channel, wherein said test channel comprises an input portion in fluidic communication with said input channel and an output portion in fluidic communication with said output channel;

endothelial cells disposed within at least one portion of said test channel; and

an output additive channel, wherein said output additive channel is in fluidic communication with said output portion of said test channel;

b) an input channel reservoir in fluidic communication with said input channel;

c) an output additive channel reservoir in fluidic communication with said output additive channel, said output additive channel reservoir comprising one or more reagents that inactivate a native coagulation cascade of blood; and

d) a pressure source adapted to apply pressure to both said input channel reservoir and said output additive channel reservoir.

11. The system of claim 10 , wherein said output additive channel is configured to provide a fluidic resistance that is proportional to the fluidic resistance of said input channel.

12. The system of claim 10 , wherein said output additive channel comprises a first fluidic resistor, and input channel comprises a second fluidic resistor.

13. The system of claim 10 , wherein said endothelial cells are living cells.

14. The system of claim 13 , wherein said living cells form a lumen.

15. The system of claim 1 , said pressure source is fluidically connected in parallel with both said input channel reservoir and said output additive channel reservoir.

16. The system of claim 6 , said pressure source is fluidically connected in parallel with both said input channel reservoir and said output additive channel reservoir.

17. The system of claim 10 , said pressure source is fluidically connected in parallel with both said input channel reservoir and said output additive channel reservoir.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Oct 28, 2025
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: EMULATE, INC.
Reel/Frame 073365/0249 →
RELEASE OF SECURITY INTEREST Recorded Oct 20, 2025
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: EMULATE, INC.
Reel/Frame 073116/0888 →
SECURITY AGREEMENT Recorded Aug 25, 2021
From: EMULATE, INC.
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 057311/0564 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 23, 2020
From: JANSSEN BIOTECH, INC.
To: EMULATE, INC.
Reel/Frame 054150/0544 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 18, 2018
From: LEVNER, DANIEL; HINOJOSA, CHRISTOPHER DAVID; WEN, NORMAN; FRASER, JACOB; NGUYEN, JUSTIN; BARRILE, RICCARDO; HAMILTON, GERALDINE; KARALIS, CATHERINE; PARK, HYOUNG SHIN; VARONE, ANTONIO; VAN DER MEER, ANDRIES; OTIENO, MONICAH; CONEGLIANO, DAVID
To: EMULATE, INC.; JANSSEN BIOTECH, INC.
Reel/Frame 045579/0628 →
Continuity (2)
Provisional Application 62361274 · Jul 12, 2016
Related Publication 20180017586A1 · Jan 18, 2018